Becton Dickinson & Company: Medical Device Recall in 2023 - (Recall #: Z-1240-2023)

Updated on March 25, 2026.

See the recall detail below. You can also see other recalls from the same firm in 2023.

Data Source: FDA.

Product Description:

BD Ultra-Fine Insulin Syringe 0.5mL, 8mm, 31G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326713

Product Classification:

Class II

Date Initiated: February 1, 2023

Date Posted: March 22, 2023

Recall Number: Z-1240-2023

Event ID: 91495

Reason for Recall:

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Status: Ongoing

Product Quantity: 1,129,000 units

Code Information:

GTIN: N/A Lot Number: 2038580, Exp. Date: 20270531; Lot Number: 2063298, Exp. Date: 20270531; Lot Number: 2137904, Exp. Date: 20270731

Distribution Pattern:

Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.

Voluntary or Mandated:

Voluntary: Firm initiated